3-Jan-2025
No headlines found.
Advent Technologies Proudly Supports the Wounded Warrior Project
Globe Newswire (Thu, 19-Dec 8:00 AM ET)
Advent Technologies Awarded Grant for H2VE Proposal
Globe Newswire (Tue, 3-Dec 8:48 AM ET)
George Paloumpis Rejoins Advent Technologies as Chief of Operations of its Patras Facility
Globe Newswire (Fri, 15-Nov 8:00 AM ET)
Globe Newswire (Wed, 6-Nov 8:00 AM ET)
Advent Technologies' RHyno Project awarded 34.5 Million by EU Innovation Fund
Globe Newswire (Mon, 4-Nov 8:00 AM ET)
Advent Technologies' Greek Subsidiary Awarded Grant from EU Innovation Fund for RHyno Project
Globe Newswire (Thu, 31-Oct 1:03 PM ET)
Advent Technologies Announces Management and Board Changes
Globe Newswire (Wed, 30-Oct 6:10 PM ET)
Advent Technologies Announces Breakthroughs in Membrane Electrode Assembly Technology
Business Wire (Thu, 17-Oct 9:30 AM ET)
Advent Technologies Reports Q1 2024 Results
Globe Newswire (Tue, 15-Oct 7:00 AM ET)
Advent Technologies Reports Q2 2024 Results
Globe Newswire (Tue, 15-Oct 7:00 AM ET)
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
Advent Technologies Hldgs trades on the NASDAQ stock market under the symbol ADN.
As of January 3, 2025, ADN stock price climbed to $5.37 with 11,393 million shares trading.
ADN has a beta of 2.93, meaning it tends to be more sensitive to market movements. ADN has a correlation of 0.06 to the broad based SPY ETF.
ADN has a market cap of $14.16 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, ADN traded as high as $208.80 and as low as $1.71.
The top ETF exchange traded funds that ADN belongs to (by Net Assets): VXF, CCSO.
ADN has underperformed the market in the last year with a return of -12.7%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ADN shares. However, ADN has outperformed the market in the last 3 month and 2 week periods, returning +188.7% and +24.0%, while SPY returned +4.6% and +0.1%, respectively. This indicates ADN has been having a stronger performance recently.
ADN support price is $4.57 and resistance is $5.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADN shares will trade within this expected range on the day.